ALX Oncology Holdings Inc. (NASDAQ:ALXO), a biopharmaceutical company currently valued at $93.36 million, has announced the adoption of a new equity incentive plan, effective January 16, 2025. The ...

Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

Elevation Oncology Inc (ELEV) stock saw a decline, ending the day at $0.73 which represents a decrease of $-0.05 or -6.41% from the prior close of $0.78. The stock opened at $0.78 and touched a low of ...

The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

The one-and-a-half-day symposium provides an overview of recent advances in the treatment of solid tumors with novel targeted ...

Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...

Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated ...

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he ...

Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple ...

TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene ...